BB Biotech Overview
Update this profile
Share Price
$94.03
(As of Friday Closing)
BB Biotech General Information
Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the health care system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace.
Want to dig into this profile?
We’ll help you find what you need
Learn more
BB Biotech Stock Performance
(As of Friday Closing)
Stock Price
Previous Close
52 wk Range
Market Cap
Shares
Average Volume
EPS
$94.03
$91.47
$53.34 - $94.51
$5.2B
4.47K
$12.31
BB Biotech Financials Summary
In Thousands, USD
TTM
31-Dec-2019
FY 2019
31-Dec-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
EV
3,372,676
3,628,515
Revenue
731,595
731,595
(433,126)
741,498
Net Income
681,719
681,719
(481,650)
698,285
Total Assets
3,668,549
3,668,549
3,135,316
3,734,561
Total Debt
154,810
154,810
187,905
97,527
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
BB Biotech Valuation & Funding
Deal Type
Date
Amount
Valuation/ EBITDA
Post-Val
Status
Debt
This information is available in the PitchBook Platform. To explore BB Biotech‘s full profile, request access.
Request a free trial
BB Biotech Executive Team (16)
Update this profile
Name
Title
Board Seat
Contact Info
Rudy Le Blanc
Board Member & Managing Director
Claude Mikkelsen
Director, Investor Relations
Maria-Grazia Iten-Alderuccio
Director, Investor Relations
Felicia Flanigan
Executive, Investment Management
Christian Koch Ph.D
Executive, Investment Management Team
You’re viewing 5 of 16 executive team members. Get the full list »
BB Biotech Investors
Investor Name
Investor Type
Holding
Investor Since
Participating Rounds
Contact Info
This information is available in the PitchBook Platform. To explore BB Biotech‘s full profile, request access.
Request a free trial
BB Biotech
Investments & Acquisitions (60)
Company Name
Deal Date
Deal Type
Deal Size
Industry
Lead Partner
0000000 0000000000
01-Feb-2018
00000 00000 00
00000
Drug Discovery
00000
06-Dec-2016
00000 00000 00
0000
Therapeutic Devices
0000000 00000000
27-Oct-2016
000
00000
Biotechnology
00000000 0000 0000
03-Sep-2015
00000 00000 00
000.00
Drug Discovery
Cidara Therapeutics
11-Feb-2015
Early Stage VC
0000
Biotechnology
000 0000000
You’re viewing 5 of 60 investments and acquisitions. Get the full list »
BB Biotech Exits (49)
Company Name
Exit Date
Exit Type
Exit Size
Status
Buyers
0000000 0000000000
01-Feb-2018
00000 00000 00
00000
Completed
00000000 0000 0000
03-Sep-2015
00000 00000 00
000.00
Completed
0000 000000000000
01-Aug-2014
00000 00000 00
00000
Completed
0000 000000000000
11-Mar-2014
00000 00000 00
0000
Completed
Intracellular Therapies
03-Sep-2013
PIPE
0000
Completed
You’re viewing 5 of 49 exits. Get the full list »